Prolor study confirms potential of human growth hormone
Prolor Biotech Inc. (AMEX: PBTH; TASE: PBTH), which evolves proteins for therapeutic utilizes, today reported publication of a preclinical study in the most recent online edition of “Endocrinology.”
The study shows that the human development hormone linked to Prolor’s carboxyl terminal peptide (CTP) technology has significantly increased bioactivity compared with the commercially available human development hormone. [...]